TMAO, A Gut Microbiome Derived Metabolite, and its Contribution to the Development of Cardiovascular Disease (CVD)

Documenti analoghi

• Gut Microbiome Variability in Pediatric Patients With Inflammatory Bowel Disease
  di: Katerina Maeder, et al.
  Pubblicazione: (2025)
• Distinguishing Crohn’s Disease From Non–Crohn’s Ileitis: A Gut Microbiome–Based Approach
  di: Nalini Raghunathan, et al.
  Pubblicazione: (2025)
• Gut Microbiome: An Intersection between Human Genome, Diet, and Epigenetics
  di: Abdullahi Y. Muhammad, et al.
  Pubblicazione: (2024)
• Probiotic Intervention in the Management of Urolithiasis: A Pathway to Gut Microbiome Modulation
  di: Roopa Shri Balakrishnan, et al.
  Pubblicazione: (2026)
• Gut Microbiome as a Source and Propagator of Multidrug‐Resistance: Mechanisms and Therapeutic Strategies
  di: Meghana Shashikanth, et al.
  Pubblicazione: (2026)